Long-term prognostic significance of early molecular response to imatinib in newly diagnosed chronic myeloid leukemia: an analysis from the International Randomized Study of Interferon and STI571 (IRIS)

Dr Michelle Muller; Professor Stephen O'Brien

Long-term prognostic significance of early molecular response to imatinib in newly diagnosed chronic myeloid leukemia: an analysis from the International Randomized Study of Interferon and STI571 (IRIS) Lookup NU author(s) Dr Michelle Muller Professor Stephen O'Brien



Author(s)		Hughes TP, Hochhaus A, Branford S, Muller MC, Kaeda JS, Foroni L, Druker BJ, Guilhot F, Larson RA, O'Brien SG, Rudoltz MS, Mone M, Wehrle E, Modur V, Goldman JM, Radich JP, IRIS Investigators
Publication type		Article
Journal		Blood
Year		2010
Volume		116
Issue		19
Pages		3758-3765
ISSN (print)		0006-4971
ISSN (electronic)		1528-0020



Full text for this publication is not currently held within this repository. Alternative links are provided below where available.



Publisher		American Society of Hematology
URL		http://dx.doi.org/10.1182/blood-2010-03-273979
DOI		10.1182/blood-2010-03-273979

Actions